Seelos Therapeutics, Inc.
SEELQ
$0.0005
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.09M | -27.12M | -37.88M | -51.09M | -81.19M |
| Total Depreciation and Amortization | 59.00K | 58.00K | 57.00K | 95.00K | 81.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.18M | -6.58M | 1.49M | 4.90M | 30.23M |
| Change in Net Operating Assets | 12.76M | 15.43M | 12.42M | 11.00M | 10.46M |
| Cash from Operations | -13.27M | -18.21M | -23.91M | -35.09M | -40.42M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.54M | -7.67M | -7.64M | -7.38M | -5.49M |
| Issuance of Common Stock | 13.27M | 12.34M | 20.21M | 15.73M | 11.84M |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.20M | -1.20M | -1.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -147.00K |
| Cash from Financing | 7.73M | 4.67M | 11.38M | 7.16M | 5.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.55M | -13.54M | -12.54M | -27.93M | -35.41M |